StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note released on Sunday. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of AMPE opened at $0.34 on Friday. The company has a market capitalization of $388,740.00, a PE ratio of -0.03 and a beta of 1.96. The company’s fifty day moving average price is $1.30 and its 200 day moving average price is $1.94. Ampio Pharmaceuticals has a one year low of $0.14 and a one year high of $8.30.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last issued its earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share for the quarter.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- How to Invest in Biotech Stocks
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Overbought Stocks Explained: Should You Trade Them?
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
